How breast cancer drugs exploit genomic fractures in tumors
A new study from WashU Medicine researchers identifies possible ways to make cancer drugs called PARP inhibitors more effective, including potential strategies to re-establish their effectiveness in tumors that develop resistance to this treatment.
Kaneko named director of cardiothoracic surgery
Tsuyoshi Kaneko, MD, a clinical innovator who has developed new devices and techniques for heart valve surgeries, has been named the new director of the Division of Cardiothoracic Surgery in the Department of Surgery at WashU Medicine.
Yi’s research soars with Eagles Autism Foundation
A WashU Medicine neuroscientist and fan of the Philadelphia Eagles, Jason Yi, has received a $400,000 grant to study autism spectrum disorder from the football team’s foundation.
Prozac treats rare form of epilepsy in WashU Medicine case study
WashU Medicine researchers showed that a popular antidepressant drug effectively reduced seizures for two sisters with a rare form of epilepsy.
Lenze named XPRIZE Healthspan semifinalist
Eric J. Lenze, MD, and his team at WashU Medicine’s Healthy Mind Lab are among 40 semifinalists in the XPRIZE Healthspan competition awarded $250,000 to study approaches to improve healthy aging.
Recent track standout Kelley wins NCAA Postgraduate Scholarship
WashU graduate and women’s track and field standout Emma Kelley has been awarded an NCAA Postgraduate Scholarship.
Immune ‘bouncers’ protect the brain from infection
A new study by WashU Medicine researchers found that, in mice, histamine-releasing immune cells protect the brain from infection.
Researchers identify brain cells key to facial recognition
A team led by WashU Medicine radiology associate professor Shuo Wang has identified neurons that appear to play a key role in our ability to recognize people.
AI-based breast cancer risk technology receives FDA Breakthrough Device designation
AI-based technology developed at WashU Medicine that improves breast cancer risk prediction has received Breakthrough Device designation from the Food and Drug Administration.
Blood plasma reveals shared pathways in neurodegenerative diseases
WashU Medicine researchers have identified biomarkers of Alzheimer’s, Parkinson’s and frontotemporal dementia from blood plasma, suggesting new therapeutic avenues.
View More Stories